Stock Earnings

Question 1

What are Monopar Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Monopar Therapeutics Inc has a total asset of $60, Net loss of $-16

Question 2

What are the key financial ratios for MNPR?

Accepted Answer

Monopar Therapeutics Inc's Current ratio is 12, has a Net margin is 0, sales per share of $0.

Question 3

How is Monopar Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Monopar Therapeutics Inc data is not available.

Question 4

Is Monopar Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Monopar Therapeutics Inc has a net loss of $-16

Question 5

Does Monopar Therapeutics Inc have any liabilities?

Accepted Answer

yes, Monopar Therapeutics Inc has liability of 5

Question 6

How many outstanding shares for Monopar Therapeutics Inc?

Accepted Answer

Monopar Therapeutics Inc has a total outstanding shares of 6.1

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	5	3	3	2	2	2
Research & Development	15	--	5	7	6	4
Operating Expenses	21	16	8	10	9	6
Other Non Operating Income (Expenses)	0	0	--	--	0	0
Pretax Income	-19	-16	-8	-10	-9	-6
Income Tax Expense	--	--	--	--	--	--
Net Income	-19	-16	-8	-10	-9	-6
Net Income Growth	217%	100%	-20%	11%	50%	50%
Shares Outstanding (Diluted)	7.12	3.79	2.76	12.72	12.47	10.96
Shares Change (YoY)	102%	37%	-78%	2%	14%	5%
EPS (Diluted)	-2.72	-4.22	-3.04	-0.83	-0.73	-0.58
EPS Growth	49%	39%	266%	14%	26%	41%
Free Cash Flow	-10	-6	-7	-7	-7	-4
Free Cash Flow Per Share	-1.4	-1.58	-2.53	-0.55	-0.56	-0.36
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-21	-16	-8	-10	-9	-6
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Monopar Therapeutics Inc (MNPR) Price